MTOR and cancer: The phosphoinositide three kinase (PI3K)/AKT/mammalian rapamycin target (mTOR) axis is frequently altered in various human cancers, thereby promoting tumor growth, proliferation and survival (Courtney et al., 2010; Dienstmann et al., 2014).